Skip to content

Opening book details…

About this Medicine article

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder by Namatame, Chihiro (author);Misu, Tatsuro (author);Takai, Yoshiki (author);Nishiyama, Shuhei (author);Nakashima, Ichiro (author);Fujihara, Kazuo (author);Aoki, Masashi (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Namatame, Chihiro (author);Misu, Tatsuro (author);Takai, Yoshiki (author);Nishiyama, Shuhei (author);Nakashima, Ichiro (author);Fujihara, Kazuo (author);Aoki, Masashi (author)
Publisher
Elsevier BV
Published
2021
Field
Medicine (Physical Sciences)

More by Namatame, Chihiro (author);Misu, Tatsuro (author);Takai, Yoshiki (author);Nishiyama, Shuhei (author);Nakashima, Ichiro (author);Fujihara, Kazuo (author);Aoki, Masashi (author)

Browse all works by Namatame, Chihiro (author);Misu, Tatsuro (author);Takai, Yoshiki (author);Nishiyama, Shuhei (author);Nakashima, Ichiro (author);Fujihara, Kazuo (author);Aoki, Masashi (author)